about
The European Paediatric Mycology Network (EPMyN): Towards a Better Understanding and Management of Fungal Infections in ChildrenERS statement on the multidisciplinary respiratory management of ataxia telangiectasiaAspergillus nidulans and chronic granulomatous disease: a unique host-pathogen interactionCandidal and bacterial bloodstream infections in premature neonates: a case-control study.Live Imaging of Antifungal Activity by Human Primary Neutrophils and Monocytes in Response to A. fumigatus.Aspergillus fumigatus conidial melanin modulates host cytokine response.Human leukocytes kill Aspergillus nidulans by reactive oxygen species-independent mechanisms.Systemic antifungal prescribing in neonates and children: outcomes from the Antibiotic Resistance and Prescribing in European Children (ARPEC) StudyOlfactomedin 4 Serves as a Marker for Disease Severity in Pediatric Respiratory Syncytial Virus (RSV) Infection.Human metapneumovirus: an important cause of acute respiratory illness.Favorable outcome of neonatal cerebrospinal fluid shunt-associated Candida meningitis with caspofungin.Common variable immunodeficiency and idiopathic primary hypogammaglobulinemia: two different conditions within the same disease spectrumTherapeutic drug monitoring of voriconazole.Screening of the central nervous system in children with invasive pulmonary aspergillosis.Aspergillus species intrinsically resistant to antifungal agents.Importance of neutropenia for development of invasive infections at various phases of treatment for hemato-oncological diseases in children.Bacterial respiratory pathogens in children with inherited immune and airway disorders: nasopharyngeal carriage and disease risk.Invasive fungal infections in patients with chronic granulomatous disease.The biology of pulmonary aspergillus infections.Azole-resistant aspergillosis.Impact of special patient populations on the pharmacokinetics of echinocandins.Prophylactic antibiotics should be used in children with repaired oesophageal atresia and tracheo-oesophageal fistula: The case against.Recognition and diagnosis of invasive fungal infections in neonates.Aspergillus infections in cystic fibrosis.Progress in the Diagnosis of Invasive Fungal Disease in Children.Molecular epidemiology of Aspergillus fumigatus isolates recovered from water, air, and patients shows two clusters of genetically distinct strains.Neutropenic acute acalculous cholecystitis (AAC) in a 12-year-old boy with T-acute lymphoblastic leukemia successfully managed with conservative treatment.In vivo and in vitro palatability testing of a new paediatric formulation of valaciclovir.Favorable outcome of chronic disseminated candidiasis in four pediatric patients with hematological malignancies.The role of the multidisciplinary team in antifungal stewardship.International expert opinion on the management of infection caused by azole-resistant Aspergillus fumigatus.Sputum Induction in Children Is Feasible and Useful in a Bustling General Hospital Practice.Decreased Cell Wall Galactosaminogalactan in Aspergillus nidulans Mediates Dysregulated Inflammation in the Chronic Granulomatous Disease Host.Direct multiplexed whole genome sequencing of respiratory tract samples reveals full viral genomic information.Prospective multicenter international surveillance of azole resistance in Aspergillus fumigatus.Country of birth does not influence long-term clinical, virologic, and immunological outcome of HIV-infected children living in the Netherlands: a cohort study comparing children born in the Netherlands with children born in Sub-Saharan Africa.Clinical spectrum of LIG4 deficiency is broadened with severe dysmaturity, primordial dwarfism, and neurological abnormalities.Recognition and Clinical Presentation of Invasive Fungal Disease in Neonates and Children.Compound heterozygous mutations in the C6 gene of a child with recurrent infections.Antibody deficiency in patients with ataxia telangiectasia is caused by disturbed B- and T-cell homeostasis and reduced immune repertoire diversity.
P50
Q26749001-39842D70-1053-414A-B783-AB2F5740EC45Q26775880-DC23D781-F6E5-4828-8777-C28710F2A71BQ26864717-1863209A-1AA7-499D-B89D-A44A1AC5879BQ33336582-D714069C-ED8A-44B0-B993-60EE33872119Q33901712-8B715AD9-C990-4687-A4F9-BED15C143D1AQ33939987-6B5047A2-3A42-4E2D-BAC0-752F0F6DC85EQ34529560-4B8CC2BA-285D-4055-8F54-E6BFDE0485F8Q35105787-FF35DD93-84DD-4D2C-9EB0-1336B829FEC5Q35688311-B1632220-29D3-4D32-84AF-C16F6FC0B83AQ36520478-E409D3AF-4834-4319-9FD8-B70BB95E3817Q36785910-14563481-32D3-4B64-B5C2-D24FC286F6B6Q37212722-DE81B49F-C26B-41E8-A363-B5DB51B4EA1CQ37222121-41547F46-2C76-4C94-8E16-0D7EB959739CQ37631540-47CEF901-2DB7-4FFE-BA6D-0D9F636896EDQ37775969-3904EB02-3104-4BA7-A8E5-7C6D4584DBA0Q37973112-E5A8359A-6433-441C-B1E4-CB8CAA8DA69DQ38095743-EA606F8E-42A2-418C-8942-A2CB6A6CD4C3Q38105091-D24E655A-E0FB-413E-93B5-5A0750AAFAE3Q38241048-019BA470-7185-4984-9995-316C031F4BA4Q38445489-86281F5A-6773-4532-9BFA-CF98FCAB7082Q38462784-CB19B483-EB5E-4743-BF89-D1FF26865E1BQ38665687-286DC4FB-1C4B-4473-8C91-0804F8FEB9BCQ38710801-5EBFB820-276A-4D00-9183-4764F8729399Q38833989-0DDB49C2-12EF-477B-A172-FAB9141A70DCQ39416559-5A04DC3F-4C17-40BB-9F0C-441464417E26Q39887192-DA4B0A2D-B359-45D7-813E-2CC657EEF852Q40073136-99CE766F-36AE-40E2-A9BD-B1BCFEBFEFEAQ40097071-4B6F1707-FA73-4050-8E56-E3EE5F0D1D5EQ40305132-FF0E4870-E83D-4DE0-AAAE-283F077A4244Q40438373-F090EC24-9B5C-42F0-9402-FD7CA2B889B5Q40633506-841AFAD0-3628-4C3B-A2D6-E2A4912C4777Q40639666-37CFDA01-F608-4C0B-8809-C2982A9ECA01Q40689034-72C98F3C-1309-4C54-A0E3-3FE849250EFFQ41340837-AF17BF42-D792-4B7C-B98E-169AAD7B341DQ41542809-FD6B466C-7829-40D6-899F-E9DC603507A6Q41657318-1DD1DB7A-DB72-4AAB-87A8-1D506EF714F8Q41786740-F54527F3-FB2C-42F8-BBCB-421E8D49C468Q41929675-F013985C-CE17-46A7-8F2D-004438290A52Q42234738-ED3CD77A-3624-4C5E-8DE9-C7279DA428EAQ42267640-602BF8D8-D973-4046-BCAC-7DAFCC3522A9
P50
description
biomedical researcher
@en
name
Adilia Warris
@en
Warris A
@nl
type
label
Adilia Warris
@en
Warris A
@nl
altLabel
Warris A
@en
prefLabel
Adilia Warris
@en
Warris A
@nl
P106
P31
P496
0000-0001-6586-3358